300 related articles for article (PubMed ID: 15601848)
1. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.
Narayanan R; Adigun AA; Edwards DP; Weigel NL
Mol Cell Biol; 2005 Jan; 25(1):264-77. PubMed ID: 15601848
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.
Pierson-Mullany LK; Lange CA
Mol Cell Biol; 2004 Dec; 24(24):10542-57. PubMed ID: 15572662
[TBL] [Abstract][Full Text] [Related]
3. Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus.
Moore NL; Weigel NL
Int J Biochem Cell Biol; 2011 Aug; 43(8):1157-67. PubMed ID: 21550420
[TBL] [Abstract][Full Text] [Related]
4. Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity.
Moore NL; Narayanan R; Weigel NL
Steroids; 2007 Feb; 72(2):202-9. PubMed ID: 17207508
[TBL] [Abstract][Full Text] [Related]
5. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
6. Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.
Wardell SE; Boonyaratanakornkit V; Adelman JS; Aronheim A; Edwards DP
Mol Cell Biol; 2002 Aug; 22(15):5451-66. PubMed ID: 12101239
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Sp1 activity by a cyclin A/CDK complex.
Haidweger E; Novy M; Rotheneder H
J Mol Biol; 2001 Feb; 306(2):201-12. PubMed ID: 11237594
[TBL] [Abstract][Full Text] [Related]
8. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
Shah YM; Rowan BG
Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
[TBL] [Abstract][Full Text] [Related]
9. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.
Narayanan R; Edwards DP; Weigel NL
Mol Cell Biol; 2005 Apr; 25(8):2885-98. PubMed ID: 15798179
[TBL] [Abstract][Full Text] [Related]
10. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.
Yun J; Chae HD; Choi TS; Kim EH; Bang YJ; Chung J; Choi KS; Mantovani R; Shin DY
J Biol Chem; 2003 Sep; 278(38):36966-72. PubMed ID: 12857729
[TBL] [Abstract][Full Text] [Related]
11. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.
Du J; Widlund HR; Horstmann MA; Ramaswamy S; Ross K; Huber WE; Nishimura EK; Golub TR; Fisher DE
Cancer Cell; 2004 Dec; 6(6):565-76. PubMed ID: 15607961
[TBL] [Abstract][Full Text] [Related]
12. Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.
Wardell SE; Narayanan R; Weigel NL; Edwards DP
Mol Endocrinol; 2010 Feb; 24(2):335-45. PubMed ID: 20008003
[TBL] [Abstract][Full Text] [Related]
13. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
[TBL] [Abstract][Full Text] [Related]
14. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
15. E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex.
Xu Y; Klein-Hitpass L; Bagchi MK
Mol Cell Biol; 2000 Mar; 20(6):2138-46. PubMed ID: 10688660
[TBL] [Abstract][Full Text] [Related]
16. Identification of interaction partners and substrates of the cyclin A1-CDK2 complex.
Diederichs S; Bäumer N; Ji P; Metzelder SK; Idos GE; Cauvet T; Wang W; Möller M; Pierschalski S; Gromoll J; Schrader MG; Koeffler HP; Berdel WE; Serve H; Müller-Tidow C
J Biol Chem; 2004 Aug; 279(32):33727-41. PubMed ID: 15159402
[TBL] [Abstract][Full Text] [Related]
17. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
Strobeck MW; Fribourg AF; Puga A; Knudsen ES
Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway.
Bouchard M; Giannakopoulos S; Wang EH; Tanese N; Schneider RJ
J Virol; 2001 May; 75(9):4247-57. PubMed ID: 11287574
[TBL] [Abstract][Full Text] [Related]
19. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
Aoyagi S; Archer TK
Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
[TBL] [Abstract][Full Text] [Related]
20. Accelerated cell cycle progression in osteoblasts overexpressing the c-fos proto-oncogene: induction of cyclin A and enhanced CDK2 activity.
Sunters A; Thomas DP; Yeudall WA; Grigoriadis AE
J Biol Chem; 2004 Mar; 279(11):9882-91. PubMed ID: 14699150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
